Methods Of Treating Plantar Fibromatosis
Summary
The USPTO published patent application US20260091092A1 on April 2, 2026, disclosing methods of treating plantar fibromatosis. The application (No. 19288073) was filed August 1, 2025, with inventors James P. Tursi, Luis A. Ortega, Qinfang Xiang, Saji Vijayan, Jeffrey David Lehrman, and David Hernandez. The patent covers therapeutic approaches using compounds classified under A61K 38/4886 and A61K 9/0019.
What changed
The USPTO published patent application US20260091092A1 disclosing methods of treating plantar fibromatosis in a subject or population of subjects. The application covers therapeutic compounds and formulations classified under CPC codes A61K 38/4886 (therapeutic proteins), A61K 9/0019 (pharmaceutical preparations), A61P 19/04 (musculoskeletal disorder treatments), and C12Y 304/24003 (enzyme-related treatments). The filing date was August 1, 2025, with application number 19288073.\n\nPatent applications are informational filings that establish priority dates and disclose invention details without creating immediate compliance obligations. Pharmaceutical companies developing treatments for plantar fibromatosis should review this application to assess potential freedom-to-operate considerations and competitive landscape. Medical device and pharmaceutical manufacturers may need to evaluate whether their existing or planned products fall within the scope of these claimed methods.
Archived snapshot
Apr 2, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
Methods Of Treating Plantar Fibromatosis
Application US20260091092A1 Kind: A1 Apr 02, 2026
Inventors
James P. Tursi, Luis A. Ortega, Qinfang Xiang, Saji Vijayan, Jeffrey David Lehrman, David Hernandez
Abstract
Disclosed herein are methods of treating plantar fibromatosis in a subject or a population of subjects.
CPC Classifications
A61K 38/4886 A61K 9/0019 A61P 19/04 C12Y 304/24003
Filing Date
2025-08-01
Application No.
19288073
Named provisions
Related changes
Get daily alerts for ChangeBridge: Patent Apps - Therapeutics (A61P)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from USPTO.
The plain-English summary, classification, and "what to do next" steps are AI-generated from the original text. Cite the source document, not the AI analysis.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when ChangeBridge: Patent Apps - Therapeutics (A61P) publishes new changes.